FDA NDC Directory · JSON-LD · Markdown

Lansoprazole

NDC 31722-571 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203083
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsLANSOPRAZOLE (30 mg/1)
Marketing started20200518
Package count5

External sources

Source: openFDA. Public-domain (CC0).